Intranasal vaccine for bird flu shows success in phase 1 trial
Bird flu, or avian influenza A(H5N1), continues to pose risks, prompting research on a new intranasal vaccine. A recent phase 1 trial showed promising immune responses, especially at lower doses. However, results do not confirm effectiveness against wild subtypes, and… Read More »Intranasal vaccine for bird flu shows success in phase 1 trial